GANX
Gain Therapeutics Inc.
$1.74
+$0.16(+10.13%)
20
Overall
--
Value
20
Tech
--
Quality
Market Cap
$56.80M
Volume
864.47K
52W Range
$1.41 - $3.19
Target Price
$7.71
Key Metrics Overview
| Market Cap | $56.80M | P/E Ratio | N/A |
| 52W High | $3.19 | 52W Low | $1.41 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 13.4% | 52W Position | 18.5% |
| Overall Score | 20 | Value Score | -- |
| Quality Score | -- | Technical Score | 20 |
Growth Analysis
| EPS Current Est | $-0.68 | EPS Next Est | $-0.73 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GANX | $1.74 | +10.1% | 864.47K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |